Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2018

Mar 22, 2018

32853_dirs_2018-03-21_74b3cd18-e3fe-4b9b-a28a-42173e92b501.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2018-03-19

Reporting Person: Linthwaite Stephen Christopher (President & CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-03-19 Employee Stock Option (Right to Buy) $6.33 A 95500 Acquired 2028-03-19 Common Stock (95500.0) Direct

Footnotes

F1: 12/48th of the total number of shares subject to the Option will vest on March 19, 2019 and 1/48th of the total shares subject to the Option will vest and become exercisable each month thereafter over the succeeding 36 months, such that the Option will be fully vested on March 19, 2022, subject to the recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through each applicable vest date.